Study of LAL and Recombinant Cascade Reagents Methods for Bacterial Endotoxin Testing in Pharmaceutical Products

The bacterial endotoxin method uses amoebocyte lysate reagents from the horseshoe crab (<i>Limulus polyphemus or Tachypleus tridentatus</i>) to detect and quantify bacterial endotoxin in injectable medications and medical devices. Two types of recombinant reagents have been introduced by various manufacturers, and the equivalency of these results to natural Limulus Amoebocyte Lysate (LAL) reagents has been recently assessed by the United States, European, and Japanese Pharmacopoeia. Recombinant reagents and amoebocyte lysate reagents appear to be highly comparable, according to several investigations.Limulus Amoebocyte Lysate assays are currently the gold standard. LAL is used in vitro for the precise detection of endotoxins and is based on the endotoxin-activated Factor C-mediated clotting cascade. In our quality control laboratory, we tested several categories of drug samples using different compendial methods for detection of bacterial endotoxin method that provides reliable and consistent results. Since 2024, a bacterial endotoxin test based on recombinant cascade reagent (rCR), the endotoxin sensor recombinant factor C, factor B, and pro-clotting enzyme inside of LAL, has been used as an animal-free alternative to LAL. The non-animal derived reagents rCR, which uses cloned genes from the genome of the <i>Limulus polyphemus</i> horseshoe crab to detect and measure bacterial endotoxins.In addition to providing ethical and environmental benefits over traditional LAL assays, rCR eliminates interfering Horseshoe Crab blood components, allowing for extremely specific endotoxin detection. For rCR test performance in routine setting, a comparative study was conducted of compendial bacterial endotoxin testing by LAL with alternates animal-free reagents rCR and summarize the evidence presented by using analysis of different categories of pharmaceutical products. According to the compendial endotoxin testing requirements, all results were acceptable. When the rCR assay was applied rather of the LAL test, no interference was seen in certain samples. In this study, that rCR and LAL are equivalent and comparable.

Authors

Institutions

Publication Details

Journal
PDA Journal of Pharmaceutical Science and Technology
Published
2026-03-17
DOI
https://doi.org/10.5731/pdajpst.2025-000073.1
Primary Topic
Immune Response and Inflammation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of LAL and Recombinant Cascade Reagents Methods for Bacterial Endotoxin Testing in Pharmaceutical Products

Manoj K. Pandey, Prasad Thota, Anshika Kaushik, Anil Kumar Teotia et al.
PDA Journal of Pharmaceutical Science and Technology
Immune Response and Inflammation
article

Study of LAL and Recombinant Cascade Reagents Methods for Bacterial Endotoxin Testing in Pharmaceutical Products

Manoj K. Pandey, Prasad Thota, Anshika Kaushik, Anil Kumar Teotia, Roshni Rajpali, Piyush Kumar, Dr. Meenakshi Dahiya, Dr. V. Kalaiselwan
article en

Abstract

The bacterial endotoxin method uses amoebocyte lysate reagents from the horseshoe crab (<i>Limulus polyphemus or Tachypleus tridentatus</i>) to detect and quantify bacterial endotoxin in injectable medications and medical devices. Two types of recombinant reagents have been introduced by various manufacturers, and the equivalency of these results to natural Limulus Amoebocyte Lysate (LAL) reagents has been recently assessed by the United States, European, and Japanese Pharmacopoeia. Recombinant reagents and amoebocyte lysate reagents appear to be highly comparable, according to several investigations.Limulus Amoebocyte Lysate assays are currently the gold standard. LAL is used in vitro for the precise detection of endotoxins and is based on the endotoxin-activated Factor C-mediated clotting cascade. In our quality control laboratory, we tested several categories of drug samples using different compendial methods for detection of bacterial endotoxin method that provides reliable and consistent results. Since 2024, a bacterial endotoxin test based on recombinant cascade reagent (rCR), the endotoxin sensor recombinant factor C, factor B, and pro-clotting enzyme inside of LAL, has been used as an animal-free alternative to LAL. The non-animal derived reagents rCR, which uses cloned genes from the genome of the <i>Limulus polyphemus</i> horseshoe crab to detect and measure bacterial endotoxins.In addition to providing ethical and environmental benefits over traditional LAL assays, rCR eliminates interfering Horseshoe Crab blood components, allowing for extremely specific endotoxin detection. For rCR test performance in routine setting, a comparative study was conducted of compendial bacterial endotoxin testing by LAL with alternates animal-free reagents rCR and summarize the evidence presented by using analysis of different categories of pharmaceutical products. According to the compendial endotoxin testing requirements, all results were acceptable. When the rCR assay was applied rather of the LAL test, no interference was seen in certain samples. In this study, that rCR and LAL are equivalent and comparable.

PDA Journal of Pharmaceutical Science and Technology
Institute of Management Technology (IN)
Openalex Percentile: Top 18%
Immune Response and Inflammation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.